Synaptogenix Inc (SNPX)

[blu_1]

3 months is short term use of a drug, not long term. When I say long term, I'm thinking 1-2 years or more. Take steroids, someone can take them and be OK short term, but 1 or two years down the road significant side effects may appear. Exactly when should we expect side effects to appear in Alzheimers patients on byrostatin? IDK and these trials won't do anything to bring clarity b/c they are of such very short duration. What I like about the Anavex trial is that patients can continue on the drug for two years beyond the 52 week trial. During those 2 years, they'll be tested every 3 months or so to track their long term progress and any side effects.

After the bryostatin Ph 2b results are reported, my guess is, a widely read article(s) will appear that is critical of the trial and Neurotrope, regardless of what the results are. One widely read biotech writer has it in for NTRP. This will coincide with a massive sell off of the stock and maximum shorting (both legal and illegal). The stock will crash to below $10. In a crash of this type, stops afford little protection. These severe drops on news are typical of micro cap biotechs.